Skip to main content

Table 1 Prevalence of Chlamydia trachomatis, Neisseria gonorrhea, Mycoplasma genitalium in the 3 types of specimen (Reunion Island, 2014–2015)

From: Prevalence of urogenital, anal, and pharyngeal infections with Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium: a cross-sectional study in Reunion island

 

Urogenital specimen

Pharyngeal specimena

Anal specimena

n/N

P-valuee

Prevalence (95%CId)

n/N

P-valuee

Prevalence (95CI%d)

n/N

P-valuee

Prevalence (95CI%d)

Chlamydia trachomatis infection

 Women ≤25y

19/186b

0.02

10.21 (6.26–15.49)

4/141f

0.12

2.83 (0.78–7.10)

2/36f,h

0.7

5.56 (0.68–18.66)

 Women >25y

7/159b

–

4.40 (1.79–8.86)

0/134

–

0.00 (0.00–2.72)

0/49

–

0.00 (0.00–7.26)

 MSM

2/53

 

3.77 (0.46–12.98)

2/45f

 

4.44 (0.54–15.15)

2/27f,h

 

7.41 (0.91–24.29)

 MSW ≤30y

16/212

0.05

7.54 (4.37–11.97)

1/147

0.63

0.68 (0.02–3.73)

0/2

 

0.00 (0.00–84.19)

 MSW >30y

4/124

–

3.23 (0.89–8.05)

0/88

–

0.00 (0.00–4.11)

0/1

 

0.00 (0.00–97.50)

 Other menc

2/92

 

2.17 (0.26–7.63)

1/47

 

2.13 (0.05–11.29)

0/8

 

0.00 (0.00–36.94)

Neisseria gonorrhea infection

 Women ≤25y

2/186

0.41

1.07 (0.13–3.83)

0/139

0.5

0.00 (0.02–2.62)

0/38

 

0.00 (0.00–9.25)

 Women >25y

1/159

–

0.63 (0.01–3.45)

0/133

 

0.00 (0.00–2.74)

0/50

 

0.00 (0.00–7.11)

 MSM

2/53

 

3.77 (0.46–12.98)

3/44g

 

6.81 (1.43–18.66)

2/27g

 

7.40 (0.91–24.29)

 MSW ≤30y

1/212

0.63

0.47 (0.01–2.60)

1/147

0.26

0.68 (0.02–3.73)

0/2

 

0.00 (0.00–84.19)

 MSW >30y

0/124

–

0.00 (0.00–2.93)

2/88

–

2.27 (0.28–7.97)

0/1

 

0.00 (0.00–97.50)

 Other menc

0/92

 

0.00 (0.00–3.97)

0/47

 

0.00 (0.00–7.55)

0/8

 

0.00 (0.00–36.94)

Mycoplasma genitalium infection

 Women ≤25y

5/186

0.2

2.69 (0.88–6.16)

1/145

0.5

0.72 (0.02–4.09)

0/39

0.56

0.00 (0.07–9.03)

 Women >25y

2/159

–

1.26 (0.15–4.47)

1/134

–

0.75 (0.02–4.12)

1/50

–

2.00 (0.05–10.65)

 MSM

1/53

 

1.89 (0.05–10.07)

0/45

 

0.00 (0.00–7.87)

1/27

 

3.70 (0.09–18.97)

 MSW ≤30y

5/212

0.1

2.36 (0.77–5.42)

0/147

 

0.00 (0.00–2.48)

0/2

 

0.00 (0.00–84.19)

 MSW >30y

0/124

–

0.00 (0.00–2.93)

0/88

 

0.00 (0.00–4.11)

0/1

 

0.00 (0.00–97.50)

 Other menc

2/92

 

2.17 (0.26–7.63)

0/47

 

0.00 (0.00–7.55)

0/8

 

0.00 (0.00–36.94)

  1. aPrevalence of anal and pharyngeal infections without concomitant urogenital CT, NG, or MG infection; y years; bTotal excludes one woman with CT infection for whom age was unknown; MSM men who have sex with men, MSW men who have sex with women; cmen who did not share their sexual orientation; CI confidence interval; dbinomial exact confidence interval; eFisher’s exact test; n: number of positive specimens; N total number of specimens; fTotal includes one specimen with concomitant pharyngeal and anal infections; gTotal includes two patients with concomitant pharyngeal and anal infections; hno anorectitis reported by infected patients
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us